Keros Therapeutics, Inc. (KROS)

11.03 -0.20 (-1.78%) USD  |  NASDAQ  |  Aug 28, 16:00
11.05 +0.02 (+0.18%) Pre-Market: 20:00
More

Keros Therapeutics Total Current Assets (Annual)

Total Current Assets (Annual) Chart

View Total Current Assets (Annual) for KROS.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Total Current Assets (Annual) Chart
Start Trial

Historical Total Current Assets (Annual) Data

View and export this data back to 2018. Start Trial.
Date Value
December 31, 2025 --
December 31, 2024 --
December 31, 2023 --
December 31, 2022 --
Date Value
December 31, 2021 --
December 31, 2020 --
December 31, 2019 --
December 31, 2018 --

Total Current Assets (Annual) Range, Past 5 Years

View Total Current Assets (Annual) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Total Current Assets (Annual) Benchmarks

View Total Current Assets (Annual) Benchmarks
Start Trial
Incyte Corp. Upgrade
Nurix Therapeutics, Inc. Upgrade
ACADIA Pharmaceuticals, Inc. Upgrade
Alnylam Pharmaceuticals, Inc. Upgrade
Anika Therapeutics, Inc. Upgrade